CausalSentinel

Protein Dossier — ERAP1 (Endoplasmic reticulum aminopeptidase 1)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Non-cancer illness code self-reported: ankylosing spondylitis 0.166 0.0482 5.60e-04 Wald ratio 1 cis NA
Forced expiratory volume in 1-second (FEV1) -0.00799 0.0026 0.00211 Wald ratio 1 cis NA
Non-cancer illness code self-reported: retinal detachment -0.184 0.0631 0.00349 Wald ratio 1 cis NA
Lung cancer 0.0605 0.0215 0.00488 Wald ratio 1 cis NA
Platelet count 1.45 0.519 0.00519 Wald ratio 1 cis NA
Forced vital capacity (FVC) -0.00667 0.00246 0.00679 Wald ratio 1 cis NA
Glioma -0.144 0.0561 0.0101 Wald ratio 1 cis NA
Diagnoses - main ICD10: I83 Varicose veins of lower extremities -0.0554 0.0221 0.0124 Wald ratio 1 cis NA
Non-cancer illness code self-reported: mania or bipolar disorder or manic depression 0.122 0.0522 0.0189 Wald ratio 1 cis NA
Amyotrophic lateral sclerosis 0.0529 0.0227 0.0196 Wald ratio 1 cis NA
Non-cancer illness code self-reported: hypertension -0.012 0.00518 0.0202 Wald ratio 1 cis NA
Non-cancer illness code self-reported: psoriasis 0.0609 0.0266 0.0219 Wald ratio 1 cis NA
…and 117 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-4964_67_1 ARTS1 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

169 association rows across 76 traits (149 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Endoplasmic reticulum aminopeptidase 1 levels 1e-2380 rs467735 13 GCST90247486 no MR -> candidate analysis
Blood protein levels 1e-375 rs2013717 1 GCST006585 no MR -> candidate analysis
Endoplasmic reticulum aminopeptidase 1 levels (ERAP1.4964.67 1e-321 rs17482078 5 GCST90241042 no MR -> candidate analysis
Serum levels of protein ERAP1 6e-297 rs12517853 1 GCST90088830 no MR -> candidate analysis
FCN2 protein levels 2e-123 rs11386832 1 GCST90469204 no MR -> candidate analysis
Circulating FCN2 levels 7e-119 rs30376 1 GCST90860487 no MR -> candidate analysis
Endoplasmic reticulum aminopeptidase 1 level in Chronic kidn 6e-79 rs30379 1 GCST90237762 no MR -> candidate analysis
PLXDC1 protein levels 3e-75 rs11386832 1 GCST90470263 no MR -> candidate analysis
Circulating PLXDC1 levels 1e-71 rs27044 2 GCST90860300 no MR -> candidate analysis
Protein quantitative trait loci 7e-70 rs13154629 1 GCST010900 no MR -> candidate analysis
ERAP1 protein levels 1e-55 rs35136 7 GCST90453391 no MR -> candidate analysis
Chronic inflammatory diseases (ankylosing spondylitis, Crohn 6e-54 rs469758 2 GCST005537 no MR -> candidate analysis
…and 64 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 314 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
psoriasis 0.851 common-variant locus MR: beta=0.0609, p=0.0219 (cis)
ankylosing spondylitis 0.824 common-variant locus MR: beta=0.166, p=5.60e-04 (cis)
hypertensive disorder 0.803 common-variant locus no MR -> candidate analysis
iridocyclitis 0.761 common-variant locus no MR -> candidate analysis
peeling skin-leukonuchia-acral punctate keratoses-cheilitis-knuckle pads syndrome 0.657 established (curated) no MR -> candidate analysis
anterior uveitis 0.64 common-variant locus no MR -> candidate analysis
Behcet disease 0.523 common-variant locus no MR -> candidate analysis
type 2 diabetes mellitus 0.545 common-variant locus no MR -> candidate analysis
response to xenobiotic stimulus 0.541 common-variant locus no MR -> candidate analysis
Crohn disease 0.536 common-variant locus no MR -> candidate analysis
Increased blood pressure 0.533 common-variant locus no MR -> candidate analysis
ulcerative colitis 0.528 common-variant locus MR: beta=0.032, p=0.0594 (cis)
sclerosing cholangitis 0.528 common-variant locus MR: beta=0.0557, p=0.17 (cis)
inflammatory spondylopathy 0.515 common-variant locus no MR -> candidate analysis
cardiovascular disorder 0.481 common-variant locus no MR -> candidate analysis

Of the 15 rows above, 11 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (Endoplasmic reticulum aminopeptidase 1)
gnomAD constraint pLI=2e-24, LOEUF=0.992 — LoF-tolerant
GWAS Catalog 219 unique SNPs / 463 rows
ClinVar 466 records; 1 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance